Andrew C. Haller, Ph.D. - Publications
Affiliations: | 2013 | Roswell Park . Pharmacology | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
Cell Biology, Molecular Biology, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Haller AC, Tan W, Payne-Ondracek R, Underwood W, Tian L, Morrison C, Li F. High SPDEF may identify patients who will have a prolonged response to androgen deprivation therapy. The Prostate. 74: 509-19. PMID 24375440 DOI: 10.1002/Pros.22770 | 0.594 | |||
2012 | Cheng Q, Ling X, Haller A, Nakahara T, Yamanaka K, Kita A, Koutoku H, Takeuchi M, Brattain MG, Li F. Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter. International Journal of Biochemistry and Molecular Biology. 3: 179-97. PMID 22773958 | 0.387 | |||
2012 | Haller AC, Morrison C, Tan W, Payne-Ondracek R, Underwood W, Poch M, Tian L, Mohler J, Li F. Abstract 3637: Loss of prostate derived Ets (E-twenty six) transcription factor (PDEF) predicts patients at the highest risk of metastatic prostate cancer Cancer Research. 72: 3637-3637. DOI: 10.1158/1538-7445.Am2012-3637 | 0.582 | |||
2012 | haller AC, Li F. Abstract 2871: Inhibition of androgen receptor-mediated expression of prostate derived ets transcription factor (PDEF) induces a loss of prostate cancer cell differentiation Cancer Research. 72: 2871-2871. DOI: 10.1158/1538-7445.Am2012-2871 | 0.601 | |||
2011 | Haller AC, Morrison C, Payne-Ondracek R, Tan W, Tian L, Mohler J, Li F. Abstract 4173: Prostate derived Ets (E-twenty six) transcription factor (PDEF) as a prognostic biomarker for metastatic prostate cancer Cancer Research. 71: 4173-4173. DOI: 10.1158/1538-7445.Am2011-4173 | 0.58 | |||
Show low-probability matches. |